Terms: = Pancreatic cancer AND ALK, CD246, ENSG00000171094, 238, Q9UM73, TFG/ALK
200 results:
1. Impact of a non-therapeutic laparotomy in patients with locally advanced pancreatic cancer treated with induction (m)FOLFIRINOX: Trans-Atlantic pancreatic Surgery (TAPS) Consortium study.
Theijse RT; Stoop TF; Janssen QP; Prakash LR; Katz MHG; Doppenberg D; Tzeng CD; Wei AC; Zureikat AH; Groot Koerkamp B; Besselink MG
Br J Surg; 2024 Mar; 111(3):. PubMed ID: 38456678
[TBL] [Abstract] [Full Text] [Related]
2. HIV associated malignancies presenting as acute pancreatitis: a case series.
Madela F; Anderson F; Nhlonzi GB; Thomson SR
S Afr J Surg; 2023 Nov; 61(4):234-236. PubMed ID: 38450696
[TBL] [Abstract] [Full Text] [Related]
3. Association between circulating inflammatory markers and adult cancer risk: a Mendelian randomization analysis.
Yarmolinsky J; Robinson JW; Mariosa D; Karhunen V; Huang J; Dimou N; Murphy N; Burrows K; Bouras E; Smith-Byrne K; Lewis SJ; Galesloot TE; Kiemeney LA; Vermeulen S; Martin P; Albanes D; Hou L; Newcomb PA; White E; Wolk A; Wu AH; Le Marchand L; Phipps AI; Buchanan DD; ; ; Zhao SS; Gill D; Chanock SJ; Purdue MP; Davey Smith G; Brennan P; Herzig KH; Järvelin MR; Amos CI; Hung RJ; Dehghan A; Johansson M; Gunter MJ; Tsilidis KK; Martin RM
EBioMedicine; 2024 Feb; 100():104991. PubMed ID: 38301482
[TBL] [Abstract] [Full Text] [Related]
4. Claudin 18.2 expression in digestive neuroendocrine neoplasms: a clinicopathological study.
Jiang K; Cao F; Yin L; Hu Y; Zhao X; Huang X; Ma X; Li J; Lu M; Sun Y
J Endocrinol Invest; 2024 May; 47(5):1251-1260. PubMed ID: 38060154
[TBL] [Abstract] [Full Text] [Related]
5. Morbidity after left trisectionectomy for hepato-biliary malignancies: An analysis of the National Clinical Database of Japan.
Terasaki F; Hirakawa S; Tachimori H; Sugiura T; Nanashima A; Komatsu S; Miyata H; Kakeji Y; Kitagawa Y; Nakamura M; Endo I
J Hepatobiliary Pancreat Sci; 2023 Dec; 30(12):1304-1315. PubMed ID: 37750342
[TBL] [Abstract] [Full Text] [Related]
6. Health-related quality of life and survival outcomes for patients with major depressive disorder and anxiety: A longitudinal study in pancreatic ductal adenocarcinoma.
Ji Y; Chen H; Yang Y; Zhou Y; Li H; Jin H; Xie J; Shen B
Cancer Med; 2023 Oct; 12(19):20070-20080. PubMed ID: 37746894
[TBL] [Abstract] [Full Text] [Related]
7. Predictive Factors for Delayed Gastric Emptying After Pancreatoduodenectomy: A Swedish National Registry-Based Study.
Zdanowski AH; Wennerblom J; Rystedt J; Andersson B; Tingstedt B; Williamsson C
World J Surg; 2023 Dec; 47(12):3289-3297. PubMed ID: 37702776
[TBL] [Abstract] [Full Text] [Related]
8.
Mulkidjan RS; Saitova ES; Preobrazhenskaya EV; Asadulaeva KA; Bubnov MG; Otradnova EA; Terina DM; Shulga SS; Martynenko DE; Semina MV; Belogubova EV; Tiurin VI; Amankwah PS; Martianov AS; Imyanitov EN
Int J Mol Sci; 2023 Sep; 24(17):. PubMed ID: 37686416
[TBL] [Abstract] [Full Text] [Related]
9. Opioid-Free Discharge After pancreatic Resection Through a Learning Health System Paradigm.
Boyev A; Jain AJ; Newhook TE; Prakash LR; Chiang YJ; Bruno ML; Arvide EM; Dewhurst WL; Kim MP; Maxwell JE; Ikoma N; Snyder RA; Lee JE; Katz MHG; Tzeng CD
JAMA Surg; 2023 Nov; 158(11):e234154. PubMed ID: 37672236
[TBL] [Abstract] [Full Text] [Related]
10. Quality of Life and Gastrointestinal Symptoms in Long-term Survivors of pancreatic cancer Following Pancreatoduodenectomy.
Zhang C; Zironda A; Vierkant RA; Starlinger P; Warner S; Smoot R; Kendrick M; Cleary S; Truty M; Thiels C
Ann Surg; 2024 May; 279(5):842-849. PubMed ID: 37497660
[TBL] [Abstract] [Full Text] [Related]
11. Discovery of novel arylamide derivatives containing piperazine moiety as inhibitors of tubulin polymerisation with potent liver cancer inhibitory activity.
Shi XY; Jiao H; Zhang JK; Tian XY; Guo DF; Gao J; Jia MQ; Song J; Zhang SY; Fu XJ; Tang HW
J Enzyme Inhib Med Chem; 2023 Dec; 38(1):2237701. PubMed ID: 37489043
[TBL] [Abstract] [Full Text] [Related]
12. Analysis of phase III clinical trials in metastatic NSCLC to assess the correlation between QoL results and survival outcomes.
Servetto A; Di Maio M; Salomone F; Napolitano F; Paratore C; Di Costanzo F; Viscardi G; Santaniello A; Formisano L; Bianco R
BMC Med; 2023 Jul; 21(1):234. PubMed ID: 37400832
[TBL] [Abstract] [Full Text] [Related]
13. Early-Onset pancreatic Neuroendocrine Tumors: Clinical Presentation, Pathology Features, and Oncological Outcomes.
Pulvirenti A; Hauser HF; Fiedler LM; McIntyre CA; Le T; Reidy-Lagunes DL; Soares KC; Balachandran VP; Kingham TP; D'Angelica MI; Drebin JA; Jarnagin WR; Raj N; Wei AC
Ann Surg; 2024 Jan; 279(1):125-131. PubMed ID: 37325926
[TBL] [Abstract] [Full Text] [Related]
14. SHP2 Inhibition Sensitizes Diverse Oncogene-Addicted Solid Tumors to Re-treatment with Targeted Therapy.
Drilon A; Sharma MR; Johnson ML; Yap TA; Gadgeel S; Nepert D; Feng G; Reddy MB; Harney AS; Elsayed M; Cook AW; Wong CE; Hinklin RJ; Jiang Y; Brown EN; Neitzel NA; Laird ER; Wu WI; Singh A; Wei P; Ching KA; Gaudino JJ; Lee PA; Hartley DP; Rothenberg SM
Cancer Discov; 2023 Aug; 13(8):1789-1801. PubMed ID: 37269335
[TBL] [Abstract] [Full Text] [Related]
15. Ambulatory cancer patients: who should definitely receive antithrombotic prophylaxis and who should never receive.
Verso M; Muñoz A; Connors JM
Intern Emerg Med; 2023 Sep; 18(6):1619-1634. PubMed ID: 37227679
[TBL] [Abstract] [Full Text] [Related]
16. Comparable long-term survival outcomes of endoscopic therapy versus surgical therapy for T1-2N0M0 duodenal neuroendocrine tumors.
Liu Z; Gao J; Wang P; Yin F; Zeng C; Chen Y
Surg Endosc; 2023 Jul; 37(7):5444-5452. PubMed ID: 37036503
[TBL] [Abstract] [Full Text] [Related]
17. Targeted molecular profiling of solid tumours-Indian tertiary cancer centre experience.
Gurav M; Epari S; Gogte P; Pai T; Deshpande G; Karnik N; Shetty O; Desai S
J Cancer Res Clin Oncol; 2023 Aug; 149(10):7413-7425. PubMed ID: 36935431
[TBL] [Abstract] [Full Text] [Related]
18. Association of Radiation and Procarbazine Dose With Risk of Colorectal cancer Among Survivors of Hodgkin Lymphoma.
Geurts YM; Shakir R; Ntentas G; Roberti S; Aznar MC; John KM; Ramroth J; Janus CPM; Krol ADG; Roesink JM; van der Maazen RWM; Zijlstra JM; Darby SC; Aleman BMP; van Leeuwen FE; Cutter DJ; Schaapveld M
JAMA Oncol; 2023 Apr; 9(4):481-489. PubMed ID: 36729438
[TBL] [Abstract] [Full Text] [Related]
19. Pharmacological targeting of the receptor alk inhibits tumorigenicity and overcomes chemoresistance in pancreatic ductal adenocarcinoma.
Parejo-Alonso B; Royo-García A; Espiau-Romera P; Courtois S; Curiel-García Á; Zagorac S; Villaoslada I; Olive KP; Heeschen C; Sancho P
Biomed Pharmacother; 2023 Feb; 158():114162. PubMed ID: 36571997
[TBL] [Abstract] [Full Text] [Related]
20. Association between type 2 diabetes and 5-year overall survival in early-stage pancreatic cancer: a retrospective cohort study.
Tang Z; Xu W; Zhang M
PeerJ; 2022; 10():e14538. PubMed ID: 36530401
[TBL] [Abstract] [Full Text] [Related]
[Next]
